tm logo

Trademark Search

Owners

Fennec Pharmaceuticals, Inc.

FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT

FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT
Live/Registered
REGISTERED

on 23 Jan 2024

Last Applicant/ Owned by

68 TW Alexander Drive

Research Triangle Park

NC

27709

Serial Number

97467771 filed on 21st Jun 2022

Registration Number

7288670 registered on 23rd Jan 2024

in the Principal Register

Correspondent Address

Joseph E. Washington

MORGAN, LEWIS & BOCKIUS LLP

1111 PENNSYLVANIA AVENUE, NW

ATTENTION: TMSU

WASHINGTON, DC 20004-2541

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT"

FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT

"HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT" Providing medical information and educational information in the field of medicine about the treatment and prevention of ototoxicity from cisplatin in pediatric patients Patient advocacy services, namely, promoting public awareness of pharmaceutical discount opportunities for underserved and needy communities by means of public advocacy and busRead More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Providing medical information and educational information in the field of medicine about the treatment and prevention of ototoxicity from cisplatin in pediatric patients


First Use Date in General

30th Sep 2022

First Use Date in Commerce

30th Sep 2022

Class [035]
Advertising, Business & Retail Services


Patient advocacy services, namely, promoting public awareness of pharmaceutical discount opportunities for underserved and needy communities by means of public advocacy and business administration of the patient assistance programs of others by enrolling patients in the assistance programs to assist them in saving money on their prescription medications; business administration of patient pharmaceutical reimbursement programs; business administration of a patient support and assistance program for obtaining reimbursement for prescription medicines


First Use Date in General

30th Sep 2022

First Use Date in Commerce

30th Sep 2022

Specimens


FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT specimenFENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT specimenFENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT specimenFENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT specimenFENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT specimenFENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT specimenFENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT specimen

Mark Details


Serial Number

No 97467771

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.04 -

Circles with two breaks or divided in the middle

26.01.09 -

Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle

26.01.15 -

Three circles

26.01.21 -

Circles that are totally or partially shaded

Description of Design Search

The mark consists of a design of a single line circle with two breaks, one at 1 o'clock and the second at 7 o'clock, each break is filled with a smaller shaded circle, with the word "FENNEC" to the right of the design, above the word "HEARS" all in large capital lettering, with the wording "Hearing Education, Access" appearing underneath, above the wording "& Reimbursement Support" all in smaller, stylized lowercase lettering with initial capitals.

Legal History


Show more

Status DateAction Taken
23rd Jan 2024REGISTERED-PRINCIPAL REGISTER
23rd Jan 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
16th Dec 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
15th Dec 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26th Nov 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
26th Nov 2023STATEMENT OF USE PROCESSING COMPLETE
13th Nov 2023TEAS STATEMENT OF USE RECEIVED
13th Nov 2023USE AMENDMENT FILED
22nd Aug 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
27th Jun 2023PUBLISHED FOR OPPOSITION